Corporate News
Scinai Immunotherapeutics Lt (ticker SCNI) closed the trading session of Thursday, 22 October 2026 at USD 0.64 per share, down 10.43 % from the previous close. The decline was observed over a 24‑hour period ending at 21:20 Central European Time.
- Shares traded in the last 24 hours: USD 110.3 k.
- Total shares outstanding: 570.3 k.
- Market capitalization: USD 388.4 k.
- 52‑week high: USD 15.5 (recorded on 3 November 2025).
- 52‑week low: USD 0.55 (recorded on 21 October 2026).
- 200‑day simple moving average: USD 4.73.
- Performance since the previous month‑end: -68.06 %.
The current trading price of USD 0.64 is substantially below the 200‑day moving average, indicating a steep decline relative to the longer‑term trend.
Peer Performance (Last 24 Hours)
| Stock | Ticker | % Move | Current Price | Market Cap | P/E Ratio |
|---|---|---|---|---|---|
| Beeio Honey | BHNY.TA | 0 % | ILA 205.3 | ILA 10.5 mn | 50 |
| Alarum | ALAR.TA | +14.69 % | ILA 47 | ILA 11.2 mn | 13.37 |
| Golden Energy Power | GLDE.TA | -4.52 % | ILA 163.1 | ILA 13.4 mn | – |
| Tectona | TECT.TA | -0.63 % | ILA 144.3 | ILA 16 mn | – |
| Tefron | TFRLF.TA | -3.04 % | ILA 1,166 | ILA 45.5 mn | – |
Company Overview
Scinai Immunotherapeutics Ltd. operates in the biopharmaceutical sector, focusing on the development, manufacturing, and commercialization of biological products for inflammation and immunology (I&I). The company’s portfolio targets autoimmune and infectious diseases, aiming to address unmet medical needs through innovative therapeutic approaches.
End of report.
